Drug Type siRNA |
Synonyms COTSIRANIB COMPONENT ANTI-COX-2 SI-RNA, STP-705 COMPONENT ANTI-COX2 SI-RNA |
Target |
Action inhibitors |
Mechanism COX-2 inhibitors(Cyclooxygenase-2 inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhaseDiscovery |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Basal Cell Carcinoma | Discovery | China | 30 Nov 2023 |